Assay News and Research

RSS
Cryo-EM structures and functions of potent bispecific antibodies against multiple Omicron sublineages

Cryo-EM structures and functions of potent bispecific antibodies against multiple Omicron sublineages

Study finds α5 integrin as a potential therapeutic target in amyotrophic lateral sclerosis

Study finds α5 integrin as a potential therapeutic target in amyotrophic lateral sclerosis

Intranasally administered SARS-CoV-2 RBD-based nanoparticle vaccine provides protection against lung pathology and viral load

Intranasally administered SARS-CoV-2 RBD-based nanoparticle vaccine provides protection against lung pathology and viral load

Rapid test could determine the existence of a key driver of severe asthma

Rapid test could determine the existence of a key driver of severe asthma

New study spotlights effective strategy against COVID-19 variants: the E7 monoclonal antibody

New study spotlights effective strategy against COVID-19 variants: the E7 monoclonal antibody

BGI Genomics report: Thailand needs to take urgent action to combat cervical cancer

BGI Genomics report: Thailand needs to take urgent action to combat cervical cancer

New report highlights gaps in cervical cancer awareness in Brazil

New report highlights gaps in cervical cancer awareness in Brazil

Study shows that anti-PTM antibodies are often present in autoimmune mediated liver disease

Study shows that anti-PTM antibodies are often present in autoimmune mediated liver disease

The essential role of the MPL36 protein in leptospirosis

The essential role of the MPL36 protein in leptospirosis

New method allows the discovery of specific inhibitors of lactate transporter

New method allows the discovery of specific inhibitors of lactate transporter

Study finds that patients with systemic autoimmune rheumatic diseases had a lower antibody response than healthy controls after Omicron infection

Study finds that patients with systemic autoimmune rheumatic diseases had a lower antibody response than healthy controls after Omicron infection

Study provides valuable insights into the UV susceptibility of SARS-CoV-2 omicron variants

Study provides valuable insights into the UV susceptibility of SARS-CoV-2 omicron variants

KIAA0930 could be a novel therapeutic target for cancer cachexia

KIAA0930 could be a novel therapeutic target for cancer cachexia

Uruguay needs to increase cervical cancer screening rates to reduce mortality, report reveals

Uruguay needs to increase cervical cancer screening rates to reduce mortality, report reveals

STEMCELL Technologies celebrates 30 years with unprecedented annual growth

STEMCELL Technologies celebrates 30 years with unprecedented annual growth

Cervical fibroblasts in cervical insufficiency patients show impaired responses to progesterone

Cervical fibroblasts in cervical insufficiency patients show impaired responses to progesterone

Tumor-derived GDF-15 suppresses immunotherapy response

Tumor-derived GDF-15 suppresses immunotherapy response

New assay identifies patients with altered p300/CBP acetylation in castration-resistant prostate cancer

New assay identifies patients with altered p300/CBP acetylation in castration-resistant prostate cancer

Using bacteriophages to treat bladder infections

Using bacteriophages to treat bladder infections

KIPA shows promise in predicting chemotherapy response in triple negative breast cancer

KIPA shows promise in predicting chemotherapy response in triple negative breast cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.